Terms: = Head and neck cancer AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Prognosis
15 results:
1. The Expression Patterns and Implications of
Syllaios A; Gazouli M; Vailas M; Mylonas KS; Sakellariou S; Sougioultzis S; Karavokyros I; Liakakos T; Schizas D
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203269
[TBL] [Abstract] [Full Text] [Related]
2. Splicing factor TRA2A contributes to esophageal cancer progression via a noncanonical role in lncRNA m
Bei M; Hao S; Lin K; Chen Q; Cai Y; Zhao X; Jiang L; Lin L; Dong G; Xu J
Cancer Sci; 2023 Aug; 114(8):3216-3229. PubMed ID: 37317053
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA malat1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2.
Duan Y; Yue K; Ye B; Chen P; Zhang J; He Q; Wu Y; Lai Q; Li H; Wu Y; Jing C; Wang X
Cell Death Dis; 2023 Feb; 14(2):149. PubMed ID: 36813772
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA malat1 Regulating Lung Carcinoma Progression via the miR-491-5p/UBE2C Axis.
Dai J; Zhou N; Wu R; Du J; Miao S; Gong K; Yang L; Chen W; Li X; Li C; Wu Y
Pathol Oncol Res; 2021; 27():610159. PubMed ID: 34257576
[TBL] [Abstract] [Full Text] [Related]
5. Expression of H19 long non-coding RNA is down-regulated in oral squamous cell carcinoma.
Vishwakarma S; Pandey R; Singh R; Gothalwal R; Kumar A
J Biosci; 2020; 45():. PubMed ID: 33410422
[TBL] [Abstract] [Full Text] [Related]
6. LncRNA-malat1 is a promising biomarker for prognostic evaluation of tongue squamous cell carcinoma.
Hu Y; Zheng L; Zhang J; Shen Y; Zhang X; Lin L
Eur Arch Otorhinolaryngol; 2020 Nov; 277(11):3155-3160. PubMed ID: 32383096
[TBL] [Abstract] [Full Text] [Related]
7. Novel insights into laryngeal squamous cell carcinoma from association study of aberrantly expressed miRNAs, lncRNAs and clinical features in Bulgarian patients.
Garo Kyurkchiyan S; Miroslavov Popov T; Stancheva G; Rangachev J; Ivanov Mitev V; Petrova Popova D; Petrova Kaneva R
J BUON; 2020; 25(1):357-366. PubMed ID: 32277655
[TBL] [Abstract] [Full Text] [Related]
8. malat1 rs619586 polymorphism functions as a prognostic biomarker in the management of differentiated thyroid carcinoma.
Wang ML; Liu JX
J Cell Physiol; 2020 Feb; 235(2):1700-1710. PubMed ID: 31456244
[TBL] [Abstract] [Full Text] [Related]
9. LncRNA UCA1/miR-124 axis modulates TGFβ1-induced epithelial-mesenchymal transition and invasion of tongue cancer cells through JAG1/Notch signaling.
Zhang TH; Liang LZ; Liu XL; Wu JN; Su K; Chen JY; Zheng QY
J Cell Biochem; 2019 Jun; 120(6):10495-10504. PubMed ID: 30635938
[TBL] [Abstract] [Full Text] [Related]
10. A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma.
Hussein AA; Forouzanfar T; Bloemena E; de Visscher J; Brakenhoff RH; Leemans CR; Helder MN
Br J Cancer; 2018 Sep; 119(6):724-736. PubMed ID: 30131545
[TBL] [Abstract] [Full Text] [Related]
11. Increased malat1 expression predicts poor prognosis in esophageal cancer patients.
Huang C; Yu Z; Yang H; Lin Y
Biomed Pharmacother; 2016 Oct; 83():8-13. PubMed ID: 27470544
[TBL] [Abstract] [Full Text] [Related]
12. Long noncoding RNA malat1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2.
Wang W; Zhu Y; Li S; Chen X; Jiang G; Shen Z; Qiao Y; Wang L; Zheng P; Zhang Y
Oncotarget; 2016 May; 7(18):25668-82. PubMed ID: 27015363
[TBL] [Abstract] [Full Text] [Related]
13. Long Non Coding RNA malat1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.
Zhou X; Liu S; Cai G; Kong L; Zhang T; Ren Y; Wu Y; Mei M; Zhang L; Wang X
Sci Rep; 2015 Nov; 5():15972. PubMed ID: 26522444
[TBL] [Abstract] [Full Text] [Related]
14. malat1 might be a predictive marker of poor prognosis in patients who underwent radical resection of middle thoracic esophageal squamous cell carcinoma.
Cao X; Zhao R; Chen Q; Zhao Y; Zhang B; Zhang Y; Yu J; Han G; Cao W; Li J; Chen X
Cancer Biomark; 2015; 15(6):717-23. PubMed ID: 26406400
[TBL] [Abstract] [Full Text] [Related]
15. Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression.
Kuo IY; Wu CC; Chang JM; Huang YL; Lin CH; Yan JJ; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
Int J Cancer; 2014 Aug; 135(3):563-73. PubMed ID: 24407731
[TBL] [Abstract] [Full Text] [Related]
